Class I HDAC inhibition reduces DNA damage repair capacity of MYC-amplified medulloblastoma cells
ConclusionOur study identifies the combination of entinostat with olaparib as a new potential therapeutic approach forMYC-driven Group 3 MB.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer & Oncology | Gastroschisis Repair | Genetics | Medulloblastoma | Neurology | Study